rhodioloside has been researched along with Bone Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, A; Cai, W; Li, J; Liu, H; Liu, J; Liu, Y; Long, Y; Tan, M; Xiao, T; Xie, L; Yang, X; Zeng, W | 1 |
| Chen, X; Huang, L; Huang, Z; Lin, W; Lv, C; Wang, L; Yang, S; Zhu, X | 1 |
2 other study(ies) available for rhodioloside and Bone Neoplasms
| Article | Year |
|---|---|
Inhibiting ROS-TFEB-Dependent Autophagy Enhances Salidroside-Induced Apoptosis in Human Chondrosarcoma Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Bone Neoplasms; Cell Line, Tumor; Chondrosarcoma; Glucosides; Humans; Phenols; Reactive Oxygen Species; Rhodiola; Signal Transduction | 2017 |
Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Janus Kinase 2; Osteosarcoma; Phenols; Signal Transduction; STAT3 Transcription Factor | 2019 |